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ABSTRACT 
 
Background: 
Development of collateral blood vessels is an important compensatory 
mechanism in response to impaired blood flow due to artery 
occlusion/stenosis. Several inflammatory cell subpopulations including T 
lymphocytes are involved in such process. Stabile and colleagues showed 
that CD4+ and CD8+ T cell subsets are both necessary for efficient 
arteriogenesis. However the contribution of different CD4+ T cell subsets such 
as T helper (Th) or the immunosuppressive regulatory CD4+CD25+ T cells (Treg) 
in collateral responses is largely unknown.  
 
Aim of the study:  
The present study aims at characterizing the role of Th1, Th2 and Treg in the 
growth of collateral vasculature following artery occlusion. 
  
Methods:  
A mouse model of peripheral ischemia by surgical femoral artery occlusion 
(hindlimb ischemia model) in CD4 knockout mice (CD4-/-) lacking CD4 T cells 
was used. These mice displaying impaired collateral responses, were used as 
recipients in rescue experiments in which was studied the effect of i.v. 
injection (reconstitution) of different CD4+ T cell subsets purified from wild-type 
animals. Blood perfusion and limb function impairment were measured over 
 4 
time by laser Doppler imaging and by a semiquantitaive ambulatory 
impairment clinical score, respectively. 
 
Results: 
Reconstitution with CD4+ naïve (composed of effector cells) but not memory T 
cells (comprising both effector and Treg) restored the capacity to recover 
blood flow and limb function of CD4-/- mice. In addition CD4+ memory T cells 
depleted of the Treg cell subset were effective in restoring collateral response 
in recipient animals. Furthermore in vitro polarized Th1 but not Th2 cells 
supported the recovery of blood perfusion and limb function following 
femoral artery occlusion.  
 
Conclusions: 
Altogether these data indicate that Th1 but not Th2 cells act as positive 
regulators of collateral vessels development while Treg cells inhibit such 
response. The identification of specific circulating cellular subsets playing 
either as positive or negative regulators of collaterals growth may be 
exploited for the identification of novel easily detectable molecular markers 
for the assessment of the individual capacity to compensate vascular 
occlusion and for the design of novel therapeutic approaches for peripheral 
and cardiac ischemic diseases.  
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GENERAL INTRODUCTION: 
 
Peripheral artery diseases are the leading causes of death in developed 
countries. Development of collateral blood vessels is an inherent 
compensatory mechanism in response to impaired blood flow. Arteriogenesis, 
consisting in the remodeling of pre-existing small arterioles into larger vessels, is 
the critical process leading to increased collateral flow. The individual ability 
to mount collateral circulation following artery occlusion/stenosis markedly 
influences the clinical consequences of ischemic diseases such as, for istance, 
intermittent claudication or angina pectoris. Coronary artery disease and 
peripheral obstructive arteriopathy strictly correlate to senescence, 
dyslipidemia, diabetes, etc. These factors are often associated with 
dysregulation of immune function. To date, effective pharmacological 
approaches to enhance collateral circulation are lacking, suggesting that it is 
very important to better understand the cellular and molecular events 
regulating arteriogenesis. 
The idea of promoting angiogenesis is still an unexplored therapeutic 
approach for the treatment of ischemic tissues endowed with a terminal 
blood supply, such as myocardium and limbs. 
Ischemic cardiovascular and cerebrovascular diseases represent the leading 
causes for mortality in Western countries (Lifton et al., 2001). Functional 
recovery of ischemic tissues/organs relies on the re-establishment of blood 
perfusion through collateral networks that supply oxygenated blood to 
specialized cells. In response to ischemic insults, most tissues display notable 
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capacities to compensate low levels of oxygen by means of vascular 
remodeling, angiogenesis, vasodilation, arteriogenesis, and hematopoiesis. 
Fine molecular mechanisms control these important processes of oxygen 
compensation, and involve induction of a distinct set of gene products 
regulating the transcriptional activation of vascular and hematopoietic 
modulators (Boutin et al., 2008; Makino et al., 2001). For instance, hypoxia 
inducible factors 1 and 2 (HIF-1 and HIF-2) are often upregulated in order to 
promote the expression of several target genes such as nitric oxide (NO), 
vascular endothelial growth factor  (VEGF) and erythropoietin (EPO), which in 
turn induce angiogenesis, vasodilation, and hematopoiesis (Boutin et al., 
2008; Makino et al., 2001; Cao, 2009; Lendahl et al., 2009).  
However, acute responses to hypoxia may not necessarily be beneficial for 
the functional recovery of ischemic tissues. For example, HIF-induced VEGF 
potently induces vascular permeability, which promotes the environmental 
conditions leading to edema in ischemic tissues (Eriksson et al., 2003; Senger 
et al., 1983). Increased angiogenesis occurring in hypoxic areas and 
supported by increased VEGF expression reduces the average distance of 
cells from the nearest blood vessel. As oxygen diffusion is inversely correlated 
with such distance, angiogenesis is essential for re-establishing normoxic 
conditions. However the formation of new capillaries also increases peripheral 
resistance. Hence, perfusion recovery is achieved only if a concomitant 
increase in the number of conductive vessels takes place.  
Differently, arteriogenesis is not driven by hypoxia but rather occurs in 
response to increased fluid shear stress as a consequence of vessel occlusion, 
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and consists in the remodeling and growth of collateral arterioles from pre-
existing anastomoses. Consequently the blood flow, downstream the site of 
vessel occlusion, is recovered. 
 
VASCULOGENESIS A GENERAL OVERVIEW: 
 
In vertebrates organogenesis, blood vessels represent one of the first 
anatomical structures reaching a functional state (Risau & Flamme, 1995); 
such event is a fundamental prerequisite for the evolution of complex 
organisms which develop an increasing need for oxygen and nutrients and 
require the removal of metabolic waste products.  
Vascular growth is a complex phenomenon which continues also in adult life, 
both in physiological and pathological conditions, either in the form of cyclic 
processes such as decidual arteriogenesis, or in response to acute or chronic 
stress, occurring in atherosclerotic vascular disease, chronic inflammation, in 
the hypoxic environment of growing malignancies, or in response to physical 
training (Hänze et al., 2007).  
Importantly, most major causes of disease in humans involve changes in tissue 
vascularization and oxygen availability (Semenza, 2007). 
A detailed understanding of the mechanisms regulating vasculogenesis in 
physiologic and pathologic conditions, represents the basis for the design of 
therapeutic approaches involving vascular growth stimulation or inhibition.  
The formation of the earliest blood vessels (around embryonic day E18 in 
humans, E6.5 in mice) occurs through vasculogenesis in all mammals. 
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Vasculogenesis relies on complex serial events including mesoderm formation, 
the establishment of the endothelial cell (EC) lineage (so-called angioblasts), 
their organization into cord-like vascular structures, lumen formation, and 
finally the organization of early vessels into vascular networks. The vascular 
system and the primordial blood cells originate from the mesoderm, one of 
the three germ layers that are formed during early embryogenesis. (Risau & 
Flamme, 1995). The term vasculogenesis indicates the process leading to the 
formation of the earliest primary vascular network, consisting of precursors of 
major vessels connected by the honeycomb-like plexus, (Yancopoulos et al., 
2000). 
 It is debated whether vasculogenesis occurs also in postnatal life (Luttun & 
Carmeliet, 2003; Péault, 2010). In adult circulation, cells expressing molecules  
such as CD34 and VEGF-2R characteristic of embryonic hemangioblasts, as 
well as VEGF, granulocyte macrophage colony-stimulating factor (GM-CSF), 
basic fibroblast growth factor (bFGF), and insulin-like growth factor (IGF-1) 
mediating their mobilization and/or differentiation (Pelosi et al., 2002;  
Carmeliet, 2000), have been detected. 
On the other hand, other authors restrict vasculogenesis to a well defined 
time frame occurring during early embryogenesis (Hänze et al., 2007; 
Semenza, 2007) and consider inappropriate the use of such term to describe 
adult blood vessel development (Ferguson et al., 2005). In addition although 
environmental factors may modify the vasculogenic program in the embryo, 
genetic predetermination governs vasculogenesis. 
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Vasculogenesis and angiogenesis during development and differentiation. The 
mesodermal progenitor cells derived from embryonic stem cells (ESC) differentiate 
into various vascular and hematopoietic cells. Vascular progenitor cells (VPC) are bi-
potentials that can differentiate into either pericyte/vascular smooth muscle cells 
(VSMC) or endothelial cells (EC) lineage. Hemangioblasts generate the blood island 
composed of endothelial progenitor cells, also called angioblasts (EPC) and 
hematopoietic stem cells (HSC). EPC differentiate into EC and form vessel tubes, 
whereas HSC further differentiate into lymphoid/myeloid lineage. Nascent vessels are 
stabilized by vascular mural cell coverage and extracellular matrix. 
 
                                                                                         
 
                                        Adapted from: Furuya M. et al., Vasc Health Risk Manag. 2005 
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ANGIOGENESIS: 
 
 
Angiogenesis comprises capillary growth either by sprouting from or by 
splitting of pre-existing vascular structures (intussusception) (Risau, 1997). 
During development, angiogenesis establishes a functional circulation in 
previously avascular tissues. While vasculogenesis forms the primary vascular 
plexus in endo- and mesoderm-derived organs, ectoderm-derived tissues 
such as the brain, receive blood supply by means of angiogenesis 
(Pardanaud et al., 1989). 
Physiological angiogenesis is a tightly controlled process critically dependent 
on the interaction of the endothelium with the environment and regulated by 
cytokines and growth factors (Chung et al., 2010). 
Sprouting angiogenesis is initiated by vascular leakage and local degradation 
of the basal membrane (BM) of the mother vessel. In response to local 
hypoxia, the release of proangiogenic factors such as VEGF induces 
proteolytic degradation of the extracellular matrix (ECM) by ECs membrane  
metalloproteinases (MMPs). In this context, ECs proliferate and migrate 
toward gradients of proangiogenic factors. Vessels subsequently  mature and 
finally acquire tissue-specific properties (Risau, 1997; Carmeliet, 2000; Fischer 
et al., 2006).  
A preceding NO-mediated local increase in vascular diameter has especially 
been described for pathological angiogenesis (Carmeliet, 2000). Leaking 
plasma proteins then form a scaffold for migrating ECs in a 
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platelet/endothelial cell adhesion molecule-1(PECAM-1/CD31)/Vascular 
endothelial-Cadherin/Src kinase- mediated process (Eliceiri et al., 1999). 
First of all, VEGF leads to increased permeability. Subsequently, angiopoietin-2 
(Angpt-2), the physiological antagonist of Angpt-1, destabilizes the matrix, 
with a subsequent partial degradation of the BM and surrounding ECM as well 
as proteolytic activation of angiogenic growth factors (Carmeliet, 2000). 
Angpt-2 activated MMPs and proteolytic enzymes liberate matrix-bound pro- 
and antiangiogenic mediators in an orchestrated sequence, and regulate 
the biological activities of factors such as VEGF by proteolytic cleavage 
(Fischer et al., 2006). 
Next, some ECs acquire an activated phenotype characterized by 
upregulated expression of adhesion molecules in response to inflammatory 
mediators and hemodynamic forces, active mitosis and migration.  
Hypoxia drives angiogenesis through intracellular stabilization of the hypoxia-
inducible factor (HIF-1) and subsequent induction of VEGF expression. 
Importantly, leukocytes play an important role in angiogenesis. In fact, 
monocytes/macrophages function as cellular regulators of angiogenesis, and 
are recruited to sites of active angiogenesis by chemokines such as VEGF-A 
and placental growth factor (PIGF) (Bernardini et al., 2003; Barleon et al., 
1996) to exert subpopulation-specific effects (Carmeliet, 2003).  
Both vasculogenesis and angiogenesis lead to chord-like EC alignments (Zeeb 
et al., 2010), which form vascular networks by fusion, giving rise to anastomosis 
and lumen formation.  
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Lumen formation occurs either by intracellular vacuoles association or by 
formation of an internal extracellular lumen from ECs solid cilinders. These 
phenomena seem to differ in physiological and pathological conditions; 
sprouting and lumen formation can occur either at the same time or in 
sequence, and pathways appear to be context-specific. In fact, lumenization 
based on vacuolation has been for istance observed epecially for isolated 
ECs lacking cell–cell contacts (Iruela-Arispe & Davis, 2009). Recent data 
supported the model of extracellular lumen origin. VEGF is necessary for 
lumen formation (Iruela-Arispe & Davis, 2009). Angpt-1 increases vessel 
diameter, while Thrombospondin-1 and tubedown-1 reduce it (Fischer et al., 
2006). Once functional vessels have been generated, mechanical factors 
displace genetic pre-specifications in determining lumen diameter (Jones et 
al., 2006). 
Angiogenic vascular morphogenesis enters its resolution phase when the 
activated, proteolytic phenotype of the invading tip cell is “turned off” by EC-
pericyte contacts. Tip cell MMP activity is downregulated and replaced by an 
activation of its inhibitors TIMP-2 and -3 (Saunders et al., 2006). A 
downregulation of major angiogenic factors such as VEGF, and a rise in local 
levels of plateled-derived growth factor (PDGF), transforming growth factor β1 
(TGFβ1) and Angpt-1 occur (Chung et al., 2010). 
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During angiogenesis, endothelial cells are activated by ischemia and grow in the 
direction of angiogenic signals. The endothelial cells fuse and develop a lumen, 
thereby forming a new, small capillary vessel. 
 
                                          Adapted from: van Oostrom M.C. et al., J. Leuk.Biol. 2008                                                  
ARTERIOGENESIS: 
 
While angiogenesis refers to the process of growing new blood vessels, 
arteriogenesis involves remodeling of existing arterial vessels (Cao, 2009; Tirziu 
et al., 2005). In fact, arteriogenesis is characterized by the increase in caliber 
of arteriolar anastomoses to collateral vessels. These vessels can grow 
considerably, in order to re-establish blood perfusion following artery stenosis 
or occlusion. While angiogenesis is triggered by hypoxia, arteriogenesis is 
independent of oxygen levels and usually occurs in a non-hypoxic 
environment. It is instead promoted by changes in fluid shear stress (FSS) 
forces sensed by the vascular endothelium  (Heil, et al., 2004). 
Hence the differences between angiogenesis and arteriogenesis reside in the 
triggering stimulus (ischemia vs shear stress), the mechanism involved and the 
result. In fact while capillaries are structurally simple tubes made of 
endothelial cells, with no additional wall structures, arteriogenesis implies a 
complex process including coordinated proliferation of endothelial, smooth 
muscle and fibroblasts accompanied by extensive tissue remodeling. 
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Collaterals originate, at least in part, from pre-existing vessels located proximal 
to the site of arterial obstruction and therefore proximal to the ischemic tissue 
(Heil, et al., 2004; Schaper & Buschmann, 1999). Although in normal conditions 
little or no flow occurs in these vessels, following sudden occlusion or a slow 
progressing stenosis of their companion main conductive artery, flow 
increases along with shear stress and promotes their opening. Hence, the 
collateral vessel wall now senses various pronounced mechanical forces, and 
augmented blood flow directly increases fluid shear stress (FSS). It can be 
estimated using the following equation, due to Newtonian fluid dynamics:   
 
τ = 4ηQ/πR3 
 
This equation includes blood viscosity (η) and the internal radius of the vessel 
(R), indicates that increased blood flow (Q) will directly result in increased FSS 
(τ)(Cox ,1979). 
Moreover, the wall of the collateral arterioles is influenced by pressure-related 
forces like longitudinal-, circumferential-, and radial wall stresses. Tension of 
the vessel wall, structurally weakened by matrix digestion and by intravascular 
pressure, increases the circumferential wall stress, a known activator of 
smooth muscle cells (SMCs) proliferation (Scheel el al., 1979). Mature 
collateral vessels differ only in minor histological aspects from normal arteries 
of the conductance type: they show a thicker muscular component and 
contain more collagen. Proliferation of EC and SMC, and ECM remodeling 
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determine an increased lumen size with subsequent enhanced perfusion to 
the ischemic tissue (Schaper & Scholz., 2003).  
Collateral response can be considered an inflammatory process involving the 
infiltration of different leukocyte subsets. Compelling evidences indicate that 
monocyte/macrophages as well as various lymphocyte subsets including 
cytotoxic and helper T cells as well as natural killer (NK) cells play essential role 
as positive regulators of such response (van Weel et al., 2007). 
Animal models for the study of arteriogenesis have been developed in 
rodents such as rabbit and mouse. The different nature of the triggering 
stimulus (hypoxia for angiogenesis and FSS for arteriogenesis) results in 
different anatomical localization of sites where capillaries or arterioles grow. In 
the murine model of hindlimb ischemia through surgical ligation of the 
femoral artery, no overt evidence of ischemia has been found at site where 
collaterals are actively developing (adductor muscle). This indicates that 
ischemia plays either no or at most a minor role in gene expression and that 
collateral vessels developing proximally to an arterial obstruction do not 
require the local expression of either VEGF or HIF1 (Lee et al., 2004).  
Growing collaterals are characterized by the presence of infiltrating 
leukocytes concentrated in the perivascular zone. When the expression 
profiling technology was adopted to investigate temporal patterns of gene 
expression during collateral development in the mouse model of hindlimb 
ischemia, the apparently prominent role played by genes modulating 
inflammatory response has been observed. These genes were differentially 
regulated, with many showing extremely high levels of transcriptional activity.  
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Endothelial cells are the major sensors of shear stress changes that are 
transduced into biochemical signals. Integrins (Jalali et al., 2001), tyrosine 
receptor kinases (Chen et al., 1998; Jin et al., 2003), G protein-coupled 
receptors (Chachisvilis et al., 2006), and ion channels (Davies et al., 1997; Nilius 
& Droogmans 2001) have been proposed to act as shear stress sensors on the 
endothelial cell membrane. These signal transduction cascades lead to the 
activation of endothelial cells. FSS induces multiple responses at the collateral 
endothelium. One of the early signs of endothelial activation is cell swelling 
and the expression of multiple genes involved in the recruitment of circulating 
leukocytes including chemokines, cytokines and adhesion molecules (Scholz 
et al., 2002; Hoefer et al., 2002; Unger et al., 1994; Fernandez et al., 2003; 
Deindl et al., 2003; Rissanen et al., 2003; Emanueli et al., 2002; Liu et al., 2003; 
Lee et al., 2004). In fact, activated endothelial cells display increased 
expression of intercellular adhesion molecule (ICAM-1) (Hoefer et al., 2004) 
and vascular cell adhesion molecule-1 (Scholz et al., 2000). In addition EC 
undergoing increased FSS release NO (Cai et al., 2004) as well as 
inflammatory chemokines including (CCL-2) and cytokines (such as tumor 
necrosis factor-α [TNF-α] and GM-CSF) (Hoefer et al., 2002; Luo et al., 2006),  
(Kosaki et al., 1998). Thus, the collateral endothelium switches from a 
quiescent vessel layer with very low adhesion tendency into a highly 
activated one, which is now supporting attraction, activation, and adhesion 
of leukocytes.  
Infiltrated monocytes/macrophages are present in perivascular zone. 
Monocytes/macrophages invading areas where collaterals grow, possess at 
 17 
least three key features relevant to promoting arteriogenesis: 1) 
responsiveness to chemokines and chemoattractants expressed by 
endothelial cells in response to increased fluid shear stress force (e.g. CCL-2); 
2) ability to promote fibroblasts, endothelial and smooth muscle cells 
proliferation through the release of relevant amounts of appropriate growth 
factors such as VEGF, bFGF and PDGF; 3) capacity to participate to 
extracellular matrix remodeling through the secretion of matrix 
metalloproteinases. 
Among chemokines involved in this process, a dominant role has been 
attributed to CCL-2. CCL-2 is a member of the CCL family of chemokines and 
it has been shown to be released by endothelial cells stimulated by 
interleukin-1 (IL-1) or TNF-α. Upon engagement of its cognate receptor CCR2 
expressed on memory T cells, dendritic cells and monocytes, CCL-2 
contributes to the recruitment of these cells to sites of tissue injury, infection, 
and inflammation. Moreover, in different animal models of femoral artery 
ligation the infusion of CCL-2 in the collateral circulation leads to increased 
number of monocytes surrounding growing collaterals and improved 
collateral flow (Ito et al., 1997; Hoefer et al., 2001; van Royen et al., 2003; 
Voskuil et al., 2003). On the other hand, mice genetically deficient for CCR-2 
displayed reduced monocyte infiltration and decreased arteriogenesis 
following artery occlusion (Heil et al., 2004). 
As well as CCL-2, other molecules can serve as chemoattractants favouring 
monocyte accumulation around growing collaterals vessels: monocytes 
express the VEGF receptor flt-1 also referred as VEGF receptor-1 (VEGFR-1). 
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Ligand-induced triggering of membrane VEGFR-1 elicits monocyte 
upregulation of integrins involved in the interaction with endothelial cells (Heil 
et al., 2000) and stimulates monocyte chemotaxis in vitro (Barleon et al., 
1996). In a rabbit model of femoral artery ligation, increased monocyte 
recruitment and improved collaterals growth was obtained by local infusion 
of placenta growth factor (PlGF), a selective agonist of the VEGF receptor flt-
1. Notably, the proarteriogenic effect of PlGF was abrogated in animals 
pharmacologically depleted of monocytes (Pipp et al., 2003). Furthermore 
increased TGF-β1 expression was found in growing collaterals. Local 
application of exogenous TGF-β increased collaterals growth and collateral 
conductance. In addition, in vitro treatment of monocytes with TGF-β 
upregulated the expression of the αMβ2 integrin (also known as complement 
receptor 3 or MAC-1 antigen) involved in cell adhesion to the endothelium, 
suggesting that TGF-β1 might foster arteriogenesis by improving monocyte 
recruitment (van Royen et al., 2002). It is generally accepted that infiltrating 
monocytes and macrophages orchestrate the remodeling process that leads 
to the formation of collateral arteries and contribute to the peculiar 
inflammatory environment of the anastomoses (Arras et al., 1998). They do so 
by 1) producing a pool of factors sustaining inflammation such as TNF-α thus 
increasing leukocyte recruitment, 2) upregulating matrix metalloproteinases 
(MMPs) involved in the remodeling of extracellular matrix required for the 
formation of new structures 3) stimulating the proliferation of endothelial and 
smooth muscle cells through secreted b-FGF (Baffour et al., 1992; Deindl et al., 
2003), PDGF (Arras et al., 1998; Cao et al., 2003) and VEGF. 
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At this point, monocytes have taken over the role of leading characters in the 
arteriogenic process from the endothelial cells. MMPs secreted by 
macrophages (Bergmann et al., 2006) break down the surrounding tissue, i.e., 
the extracellular matrix (ECM) and the internal elastic lamina consequently 
allowing monocytes to invade the vascular wall. This further enables 
paracrine signaling between the perivascular cells, such as pericytes and 
smooth muscle cells (SMC) and the endothelium, hence creating space for 
the growing vessel (Polverini et al., 1997). 
As a result of the loss of extracellular matrix and intravascular pressure, smooth 
muscle cells slip away from each other. This allows the vessel to enlarge, 
acquiring a vein-like appearance (Cai et al., 2000). Endothelium specific 
platelet-derived growth factor B (PDGF-B) and PDGFR expression on SMC play 
an important role in subsequent migration and recruitment of SMC to the 
subendothelial space, where they form the neointima layer (Wolf et al., 1998; 
Hellström et al., 1999). The proliferating smooth muscle cells dispose 
themselves around the growing vessel and exhibit a “synthetic” phenotype, 
defined by production of ECM, collagen, and elastin (Buschmann et al., 
1999). In this manner, the SMC reconstitute the internal elastic lamina and the 
tunica media. Growth factors such as bFGF and TNF-α are secreted by 
monocytes already present in the tissue, and facilitate the proliferation of 
vascular cells.  
The final phase in collateral growth is maturation of the vessels. This is 
characterized by reduced proliferation, migration and proteolytic activity, 
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and the differentiation of SMC to the contractile phenotype (Scholz et al., 
2000). 
During arteriogenesis collaterals can grow up to 20 times in diameter. (Wolf et 
al., 1998). Since collateral vessels grow in length as well as in width, the 
expanding vessel arranges itself in loops and turns to accommodate the extra 
length. This gives the vessels a typical corkscrew pattern (Heil et al., 2006) and 
causes a remarkable loss of dynamic forces of the fluid circulating inside.  
 
 
 
Arteriogenesis and angiogenesis are both necessary after ischemia to 
compensate the insufficient blood supply and maintain tissue function. In 
order to face an acute ischemic insult, arteriogenesis is probably a more 
effective mechanism to rescue tissue and organ function whereas the 
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formation of new vascular networks may represent a delayed phase to 
compensate tissue ischemia.  
 
 
In arteriogenesis, circulating leukocytes (green) are attracted to the activated 
endothelium. They assist in enlarging collateral anastomoses. Activated endothelial 
cells (blue), activated vascular smooth muscle cells (yellow), quiescent endothelial 
cells (gray), quiescent smooth muscle cells (brown). 
 
 
 Adapted from: van Oostrom M.C. et al., J. Leuk.Biol. 2008 
 
ROLE OF T LYMPHOCYTES SUBSETS IN THE ARTERIOGENIC RESPONSE: 
 
Other circulating cells are also known to participate in the arteriogenic 
response. Lymphocytes are observed frequently in the wall of growing 
collaterals, hence they may also have a role in arteriogenesis (Heil et al., 
2004) as they produce vascular endothelial cell growth factor (VEGF) 
(Couffinhal et al., 1999). Their specific role in arteriogenesis is still uncertain. 
Activated T lymphocytes secrete cytokines and they are able to modulate 
trafficking of other inflammatory cells, such as monocytes/macrophages. 
A role for T lymphocytes in collateral vessel development was initially 
suggested by the observation of impaired collaterogenesis in athymic nude 
mice lacking T cells but with normal monocyte and macrophage counts 
(Couffinhal et al., 1999). 
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T lymphocytes are subdivided into two major subsets depending on the 
expression of the membrane antigens CD4 or CD8. Among these two main 
subsets, several subpopulations exist based on their functional properties 
hereafter referred as functional subsets. Naïve CD4+ T cells can differentiate 
into T helper (Th) subsets based on their pattern of cytokine production. While 
T helper 1 lymphocytes produce interferon-γ (IFN-γ) but not interleukin-4 (IL-4), 
Th2 cells release IL-4 and IL-5 but not IFN-γ. T helper cells predominantly 
producing IL-17 (Th17) or IL-22 (Th22) have been described and are involved 
in chronic inflammation and in wound healing/skin diseases, respectively. In 
addition, other functional CD4+ T cell subsets exist that display regulatory 
rather than effector functions. Three subsets of these regulatory T cells have 
been described: T regulatory 1 cells (Tr1) that function via the production of 
the cytokine IL-10, T helper 3 (Th3) cells producing TGF-β, and a population of 
CD4+CD25+Foxp3+ T cells (Treg) that suppresses proliferation via a cell-
contact-dependent mechanism. 
Importantly, mice deficient in CD4 T lymphocytes showed reduced blood flow 
recovery after femoral artery ligation with concomitant decreased 
recruitment of macrophages during arteriogenesis (Stabile et al., 2003). Both 
CD4+ and CD8+ T cell subsets are necessary for efficient arteriogenesis. 
Infiltrating CD4+ T cells contribute, at least in part, by actively releasing VEGF 
and chemokines thus recruiting circulating monocytes. In the absence of 
CD4+ T lymphocytes, ischemia-induced inflammatory responses and collateral 
development are impaired compared to their wild-type (C57BL/6) littermates. 
Normal collateral response could be restored in CD4-deficient mice after 
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reconstitution with CD4+ cells isolated from wild type animals. Moreover, CD8+ 
T lymphocytes play a pivotal role in collateral response after femoral artery 
occlusion. Similarly to what observed in CD4-/- mice, animals lacking CD8+ T 
cells displayed impaired development of collaterals, that could be restored 
by systemic administration of CD8+ cells obtained from wild-type but not from 
IL-16 deficient mice (Stabile et al., 2006). Such finding, along with the 
capacity of IL-16 to act as a chemoattractant for CD4+ cells, suggests a 
pivotal role for this cytokine in the cross-talk between inflammatory CD8+ and 
CD4+ T cells in the context of collateral vessels development. 
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Arteriogenesis. (A) Without significant stenosis, there is no significant pressure gradient 
over pre-existing collateral anastomoses, which are small and barely carry blood. (B) 
Development of a significant arterial obstruction leads to a drop in pressure and 
oxygen saturation distal in the vascular bed (purple-blue colour), while proximal 
pressure and oxygen saturation proximal remain normal (red colour). The pressure 
gradient over the collateral circulation increases fluid shear stress in these arterioles. 
(C) Close-up on the cellular level. The endothelium senses increased fluid shear stress 
via its cytoskeleton, transmembrane proteins (integrins, ion channels) and the 
glycocalyx. In an activated state, the endothelium expresses adhesion molecules 
(ICAM-1), to which circulating monocytes bind via their Mac-1 receptor. Monocytes 
transmigrate into perivascular tissue, differentiate to macrophages and secrete 
growth factors and cytokines that attract further monocytes and stimulate 
proliferation of smooth muscle cells and endothelial cells. (D) Adequately developed 
collateral arteries restore distal perfusion and provide sufficiently oxygenated blood 
to distal tissues. bFGF, basic fibroblast growth factor; GM-CSF, granulocyte-
macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; MCP, 
monocyte chemoattractant protein; MMPs, matrix metalloproteinases; TGFβ, 
transforming growth factor β.  
 
 
                                                                   Adapted from: Schirmer S. H.et al., Heart. 2009 
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AIM OF THE STUDY: 
 
In this study we used a murine model of periferic ischemia (hindlimb ischemia) 
obtained through surgical ligation of left femoral artery to investigate the 
substantial role of different T lymphocyte subpopulations during the process of 
collateral vessels development.  
While the pivotal role of macrophages that infiltrate sites of growing 
collaterals and secrete factors crucial for vascular remodelling is well 
established, the contribution of T lymphocytes has been unveiled only 
recently. 
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METHODS: 
 
Angiogenic response to ischemia: 
12 weeks old mice anaesthetized with intraperitoenal injection of xylazine (40 
mg/kg) and ketamine (100 mg/kg), underwent surgical excision of the left 
femoral artery to induce unilateral hind limb ischemia. Mice body 
temperature was kept at 37°C during surgery and all post operative 
interventions. Blood flow recovery after surgical excision of the left femoral 
artery was periodically assessed over time using a LASER Doppler perfusion 
imaging (LDPI) (Moor Instruments); blood flow recovery between mid-calf and 
mid-foot region was measured. For consistent measurements, imaging was 
performed after limb hair removal and after heating to 37°C to minimize 
temperature variation. Calculated perfusion was expressed as a ratio of the 
ischemic to normal limb. Limb function and the rate and extent of the healing 
process were evaluated using a clinical derived score (Ambulatory 
Impairment Score) and a semi-quantitative score of tissue damage, 
respectively. Finally, we evaluated the number of arteries present within the 
upper thigh of 6 animals for each group 28 days after femoral artery ligation. 
Only arteries containing a continuous internal elastic lamina (as stained with 
Elastic Van Gieson) and a rim of muscular tissue were counted, this excluded 
all functional arterioles, which usually are considered resistance, rather than 
conductance vessels. 
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Histological analysis of the calf muscle: 
A delayed and reduced blood flow recovery results in an increased 
incidence of autoamputation. These events were carefully recorded. At the 
end of follow up, in every animal, we performed histological analysis of the 
C57BL/6 CD4-/- 
 
 Ischemic limb 
Laser doppler perfusion imaging follow-up 
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calf muscle located downstream to the distal point of femoral artery ligation 
and tipically subjected to ischemia after surgery. Collateral development in 
the upper limb is functionally relevant only if it reduces the extent of ischemia 
in the distal limb and consequently prevents muscle damage. We estimated 
the extent of fibrosis and muscular atrophy by Sirius red tissue staining 
expecting to observe a significant increase in the amount of fibrosis and of 
muscle fibers atrophy, caused by the more prolonged time the muscle is 
subjected to severe ischemia in mice with deficient collateral vessel 
development. 
 
Purification of CD4+ T cell subsets: 
CD4+CD25- effector T, CD4+CD25+ regulatory T and CD4+CD62L+ naïve T cells 
were isolated from age and gender-matched wild-type C57BL/6 spleens.  
Splenocytes were obtained by spleen homogenates (1 spleen yield typically 
107 splenocytes) and used to obtain cellular subpopulations. 
CD4+ untouched  cells were isolated by immunomagnetic selection (Miltenyi 
Biotechnology, Inc) followed by incubation with anti-CD25 beads, and 
negative (effector T cells) and positive (regulatory T cells) fractions were both 
collected. 
For naïve T cells, immunomagnetic isolation was performed through negative 
selection using a CD4+CD62L+ T cell isolation kit (Miltenyi Biotechnology, Inc). 
In order to analyze the role of Th1 and Th2 cells, naïve T cells were stimulated 
and cultured in polarizing conditions as follows: 
 29 
The polarization torward Th1 cells was obtained incubating naïve T 
splenocytes in plates precoated with anti-CD3 (1,5 mg/ml) in the presence of 
anti-CD28 (1,5 mg/ml), anti-IL-4 (10 mg/ml) and IL-12 (10 ng/ml). For Th2 
polarization naïve T cells were stimulated with the same doses of anti-CD3 
and antiCD-28 in the presence of IL-4 (10 ng/ml) and anti-IFN-g (10 mg/ml). 
To assess in vitro polarization, resting T cell lines were stimulated with phorbol-
myristate-acetate (10 ng/ml) and ionomycin (1 mg/ml) for 4h. Cells were then 
fixed with 2% paraformaldehyde for 20’ at 4°C and permeabilized by 
incubation with 0,5% saponine for 20’ at room temperature before staining 
with fluorochrome-conjugated anti-IFN-g and anti-IL-4. The percentages of 
IFN-g-producing/IL4- Th1 and IL-4-producing/IFN-g- Th2 cells were measured 
by flow cytometric analysis fractions by means of positive selection following 
magnetic labeling (Miltenyi Biotechnology, Inc). 
 
Rescue experiments by infusion of different subsets of T lymphocytes from 
C57BL/6 mice: 
For reconstitution experiments 106 cells belonging to the appropriate purified 
CD4+ T cell subset were injected i.v. at time of surgery.  
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RESULTS: 
 
The role of the functional subsets of CD4+ T cells Th1, Th2 and Treg cell has 
been investigated using CD4-deficient (CD4-/-) C57BL/6 mice, lacking the 
entire CD4+ subsets repertoire. In order to assess the specific contribution of 
CD4+ T cells functional subsets to collateral response, CD4-/- mice underwent 
surgical ligation of the left femoral artery and blood flow recovery kinetics 
were evaluated. Blood perfusion recovery was analyzed in wild-type and 
CD4-/- animals reconstituted or not with different CD4+ T cell subsets freshly 
isolated from wild-type mice or generated in vitro as described in materials 
and methods. 
Figure 1A shows the kinetic of blood flow in C57BL/6 and CD4-/- mice after left 
femoral artery surgical occlusion. In keeping with previous observations 
animals lacking CD4+ cell subsets display impaired blood flow recovery as 
soon as day 3 post surgery.  Blood flow recovery remains unpaired at later 
time points. The difference in blood flow between wild-type and CD4-/- 
animals is statistically significant at days 7, 14, 21 and 28 post surgery. As a 
result of reduced perfusion CD4-/- mice displayed altered limb function with 
subsequent ambulatory impairment (Figure 1B). Little acute ambulatory 
impairment was measurable in wild-type animals at days 3 and 7 post artery 
occlusion. Such impairment further decreased at later time points and 
virtually disappeared at day 28. In contrast ambulatory impairment in CD4-/- 
mice peaked at day 7 when it was 6 fold greater than that measured in wild-
type animals. 
 31 
Moreover CD4-/- mice only partially recovered ambulatory capacity at the 
end of the follow up time.  
In the next series of experiments we compared the effect on blood flow 
recovery after artery occlusion of the administration of CD4+CD25- effector T 
cells with the infusion of CD4+CD25+ regulatory T lymphocytes. CD25- and 
CD25+ T cell subsets were purified from the spleen of wild-type mice and 
injected intravenously at time of surgery. 
Effector but not regulatory T cells determined accelerated and augmented 
blood perfusion during the 4 week follow up (fig. 2A). These differences in 
blood perfusion recovery are consistent with the impairment in deambulation.  
These results indicate that the capacity to foster collateral response relies 
exclusively on the effector T cell subset. However the inability of regulatory T 
cells to promote collateral vessels growth alone does not indicate whether 
this cells population acts as negative regulator of such process.  
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Fig. 1. Impaired collateral response to acute left hindlimb ischemia induced by 
surgical artery ligation in CD4-/- (CD4 KO) mice. A) ischemic limb blood flow 
recovery evaluated by laser Doppler perfusion imaging. Calculated perfusion is 
expressed as a ratio of the ischemic to normal limb that underwent the same surgical 
procedure except for femoral artery ligation. B) Semiquantitative assessment of 
impaired use of the ischemic limb expressed through the score below: 3=dragging of 
foot, 2=no dragging but no plantar flexion, 1=plantar flexion, and 0=flexing the toes 
to resist gentle traction on the tail.* = p<0.05 t  Student’s test. 
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Fig. 2. Post-ischemical collateral vessels development recovery in CD4-/- (CD4KO) 
mice reconstituted with either effector T or regulatory T lymphocytes. A) Blood flow 
recovery in ischemic limb measured by laser Doppler perfusion imaging. Calculated 
perfusion is expressed as a ratio of the ischemic (left) to normal (right) limb that 
underwent the same surgical procedure except for femoral artery ligation. CD4-/- 
mice were reconstituted through intravenously perfusion of physiologic solution(-) or 
106 effector T cells (CD25-) or regulatory T cells(CD25+) isolated from wild-type 
C57BL/6 mice spleen. B) Semiquantitative assessment of impaired use of the ischemic 
limb expressed through the score below: 3=dragging of foot, 2=no dragging but no 
plantar flexion, 1=plantar flexion, and 0=flexing the toes to resist gentle traction on 
the tail.* = p<0.05 t Student’s test. 
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To gain a better insight into the role of regulatory T cells we initially compared 
the ability of the administration of naïve or memory CD4 T cells to modify 
collateral response to femoral artery occlusion in CD4-/- recipient mice. Of 
note, memory CD4+CD62L- but not naïve CD4+CD62L+ T cells comprise the 
CD4+CD25+ Treg subset.   
First of all we evaluated collateral vascular development and relative blood 
flow recovery and ischemic limb function in CD4-/- mice reconstituted with 
CD4+ CD62L+ naïve T cells. The infusion of naïve T cells, devoid of  regulatory T 
cells, completely restored blood flow recovery in CD4 deficient mice (Figure 
3A). In fact, kinetic of blood perfusion in naïve T cells reconstituted and wild-
type mice were almost completely identical. In contrast the infusion of 
CD4+CD62L- memory T cells that include the regulatory cells subset had no 
detectable effect on the recovery of blood flow. Next we asked whether the 
presence of Treg cells in the CD4+ CD62L- memory population played a role in 
its capacity to regulate collateral vessels growth. To this aim CD4+CD62L- 
memory T cells purified from wild type splenocytes were incubated with anti 
CD25 monoclonal antibody to deplete the CD4+CD25+ regulatory cell subset. 
The resulting cell population consisting in memory T cells devoid of regulatory 
T cells was then used to reconstitute CD4-/- mice who underwent femoral 
artery ligation. In these animals we observed complete recovery of the 
capacity to restore blood perfusion. These differences in blood perfusion 
recovery are consistent with the impairment in deambulation. These results 
suggest that Treg cells turn memory T cell population unable to foster 
collateral responses and point them out as possible negative regulators of 
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arteriogenesis.  
In order to directly analyze the contribution of Th1 and Th2 cells in post-
ischemic collateral response, purified CD4+CD62L+ naïve T cells from wild-type 
mice were cultured in polarizing conditions to generate IFN-γ-producing Th1 
and IL-4-producing Th2 effector T cell lines. To ascertain the acquisition of 
functional characteristics of Th1 and Th2 cell subsets, cytokine production was 
assessed by intracellular staining with fluorochrome-conjugated anti IFN-γ and 
anti IL-4 antibodies. 
T helper 1 and Th2 cell lines were then used to reconstitute CD4-/- mice at 
time of surgical femoral artery occlusion. Th1 but not Th2 are endowed with 
the capacity to support collaterals growth as assessed by the analysis of the 
kinetics of blood flow recovery and ambulatory impairment  (figure 4A and 
4B). Intrinsic impairment in blood flow recovery, characteristic of CD4-/- 
recipient mice, was not altered by the administration of Th2 cells, whereas Th1 
markedly improved blood perfusion and limb function. 
These results suggest that Th1 cells contribute as positive regulators of 
arteriogenesis while Th2 cells play a neutral or a negative role in such process. 
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Fig. 3. CD4-/- mice reconstituted with either naïve T lymphocytes or CD62L- memory T 
cells depleted of CD25+ Treg subset are able to re-establish the individual ability to 
mount an efficient collateral circulation following artery occlusion. A) Blood flow 
recovery in ischemic limb was measured by laser Doppler perfusion imaging. 
Calculated perfusion is expressed as a ratio of the ischemic (left) to normal (right) 
limb that underwent the same surgical procedure except for femoral artery ligation. 
CD4-/- mice were reconstituted by intravenous injection  of physiologic solution(-) or 
106 CD4+ naïve or memory T lymphocytes or memory T cells after depletion of CD25+ 
cells (memory + anti-CD25 mAb) isolated from wild-type C57BL/6 mice spleen. B) 
Semiquantitative assessment of limb function impairment.  Individual mice were 
evaluated by the assignment of the following score: 3=dragging of foot, 2=no 
dragging but no plantar flexion, 1=plantar flexion, and 0=flexing the toes to resist 
gentle traction on the tail. *=p<0.05 t Student’s test. 
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Fig. 4. Th1 but not Th2 cells are able to support collateral response giving rise to blood 
flow recovery in CD4-/- mice after surgical femoral artery ligation.  A) Blood flow 
recovery in ischemic limb measured by laser Doppler perfusion imaging. Calculated 
perfusion is expressed as a ratio of the ischemic (left) to normal (right) limb that 
underwent the same surgical procedure except for femoral artery ligation. CD4-/- 
mice were reconstituted through intravenously perfusion of physiologic solution(-) or 
106 T helper 1 (Th1) or T helper 2 (Th2) in vitro polarized from CD4+CD62L+ naïve T cells 
isolated by negative immunomagnetic selection from wild-type C57BL/6 mice 
spleen. B) Semiquantitative assessment of impaired use of the ischemic limb 
expressed through the score below: 3=dragging of foot, 2=no dragging but no 
plantar flexion, 1=plantar flexion, and 0=flexing the toes to resist gentle traction on 
the tail.* = p<0.05 t Student’s test. 
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DISCUSSION AND CONCLUSIONS: 
 
Compelling evidences point out a pivotal role for T lymphocytes in the 
orchestration of the inflammatory process underlying collateral vessels 
development. However, the specific contribution of different functional T cell 
subsets is to date still largely unknown.  
A role for T lymphocytes in collateral vessel development was initially 
suggested by the observation of impaired collaterals development in athymic 
nude mice lacking T cells that bear the α/β T cell receptor but with normal 
monocyte and macrophage counts (Couffinhal et al., 1999). 
Furthermore, Stabile and coworkers, using the hindlimb ischemia model in 
CD4- and CD8-deficient mice, described the essential role of CD4+ and CD8+ 
T cell subsets respectively for efficient arteriogenesis and development of 
collaterals (Stabile et al., 2003; Stabile et al., 2006).  
Recently, Kumamoto and coworkers, using a murine model of viral infection, 
reported that CD4+ T cells promote anti-viral CD8+ T cell responses by 
increasing the input of naïve lymphocytes in the relevant draining lymph 
node. Although the molecular mechanism underlying such CD4+ T cell 
function is still largely unknown, increased naïve T cell recruitment after viral 
infection is achieved in wild-type animals, at least in part, through the 
remodeling of the lymph node feeding arteriole to a larger diameter 
(Kumamoto et al., 2011).  
In this study we aimed at characterizing the contribution of three important 
CD4+ functional T cell subsets such as CD25+foxp3+ Treg lymphocytes, Th1 and 
 39 
Th2 cells. Taking advantage of the murine hindlimb ischemia model for the 
study of arteriogenesis and collateral response to femoral artery occlusion, we 
initially compared the capacity to recover blood flow during a four weeks 
follow up time in wild-type and CD4-deficient knockout mice. In keeping with 
other observations, CD4 knockout mice displayed impaired capacity to 
mount efficient collateral response, resulting in reduced blood flow perfusion 
and impaired limb function. Thus, CD4-deficient mice were subsequently used 
as recipient to assess whether engraftment with specific CD4+ T cell subsets, 
did rescue the capacity to recover blood flow following femoral artery 
occlusion. 
A specific CD4+ T cell subset expressing the transcription factor forkhead box 
(foxp3) and CD25 denominated CD4+CD25+ regulatory T cells (T regs) is 
specialized in the suppression of effector T cell function. Regulatory T cells 
contribute to the maintenance of immunologic self-tolerance and negative 
control of various immune responses (Sakaguchi, 2004).  
To investigate the role of regulatory T cells, we initially performed rescue 
experiments in CD4-deficient recipient mice comparing the effects of the 
administration of two CD4+ T cell subpopulations, defined by the expression of 
the low affinity IL-2 receptor CD25, on arteriogenesis. CD4+ T lymphocytes 
expressing CD25 are highly enriched in regulatory T cells, whereas CD25- cells 
are considered effector lymphocytes. When CD4-deficient mice where 
reconstituted with effector cells, their capacity to recover blood perfusion 
after femoral artery ligation was restored. On the other hand, administration 
of C4+CD25+ T cells did not improve the kinetic of blood flow recovery. These 
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results indicated that CD25- effector but not CD25+ regulatory T cells support 
inflammation leading to collateral vessels remodeling.  
In order to obtain information about the interplay between these two cellular 
subsets, we then used a different approach. We took advantage of the fact 
that, by definition, regulatory T cells had encountered their specific antigen 
and therefore belong to the memory T cell population. As a consequence of 
the encounter with cognate antigen, naïve T cells downregulate surface 
expression of CD62L and are thus phenotypically identifiable as CD62L- cells 
by flow cytometry analysis. On the contrary, naïve T cell population retains 
surface CD62L expression and falls into the CD62L+ cellular subset. Thus by 
simply separating CD4+ T cells into naïve (CD62L+) and memory (CD62L-) 
subsets we obtained two populations: the first (CD62L+, naïve) devoid of 
regulatory cells while the second (CD62L-, memory) comprising both effector 
and regulatory cells. As shown in the rescue experiments illustrated in Fig. 3, 
naïve but not memory CD4+ T cells were capable of restoring collateral 
responses thus indicating that the presence of Treg cells in the memory 
population might have exerted a dominant inhibitory effect on arteriogenesis. 
Consistent with such hypothesis, CD62L- memory cells depleted of the CD25+ 
cell subset became effective in restoring collateral response. 
The involvement of CD4+CD25+ Treg cells in the regulation of collateral 
response to ischemia has been recently proposed. Using CD28-deficient mice 
that lack T regs cell subset or by depleting Tregs in wild-type animals through 
the administration of an anti-CD25 antibody, Zouggari and coworkers recently 
showed increased efficiency in blood flow recovery after femoral artery 
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ligation (Zouggari et al., 2009). The authors speculated that the suppressive 
effect of T regs was due to their intrinsic inhibitory action on effector immune 
cell response. Interestingly, CD28-deficient mice that display severely reduced 
T regs numbers, are also characterized by enhanced type 1 effector T cell 
responses (Lenschow et al., 1996). Notably, several studies have indicated 
that Type 1 T cells are more susceptible than type 2 T lymphocytes to T regs-
mediated suppression (Cosmi et al., 2004). It can be hypothesized that T regs 
might inhibit neovascularization by exerting preferential suppression of a 
particular functional subset of effector T lymphocytes, the IFN-γ-producing 
type 1 T cells. 
Finally, we addressed the role of two major CD4+ effector T cell subsets, 
namely Th1 and Th2. Although no formal demonstration is yet available, 
several observations indicate that type 1 T lymphocytes may foster post-
ischemic neovascularization, whereas interleukin IL-4-producing type 2 cells 
may play a neutral or negative role. In support of this view it has been 
recently showed that 1) natural killer cells, that release large amounts of IFN-γ 
and are pivotal in the polarization of T helper cell responses toward the type 1 
phenotype (Martin-Fontecha et al., 2004), play as essential positive regulators 
of post-ischemic neovascularization (van Weel et al., 2007) ; 2) IL-16 that is 
crucial for normal recruitment of inflammatory cells at site of collateral vessels 
development (Stabile et al., 2006), has been also shown to preferentially 
recruit Th1 lymphocytes (Lynch et al., 2003); 3) reduced collateral response is 
evident in Balb/c compared to C57BL/6 mouse strain (Helisch et al., 2006). 
Interestingly, Balb/c mice have higher numbers of circulating Tregs compared 
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to C57BL/6 (Chen et al., 2005) and are prone to mount type 2 T cell responses 
while C57BL/6 mice display a Th1-skewed phenotype. 
Our experimental approach consisted in generating T cell lines in vitro from 
freshly isolated naïve CD4+ T cells by polyclonal stimulation in the presence of 
cytokines promoting the polarization of T cells toward Th1 or Th2 phenotypes. 
Before use, the functional phenotype of these cell lines defined as T helper 1 
when producing large amounts of INF-γ but low or none IL-4 or IL-17, or as T 
helper 2 when releasing large amounts of IL-4 but low or none IFN-γ was 
assessed in vitro. 
Rescue experiments involving the transplantation of in vitro polarized Th1 cells 
showed that reconstitution with this specific subset alone was effective in 
restoring almost completely the capacity of mice to recover blood flow and 
limb function, after the surgical procedure of femoral artery ligation. On the 
other hand, the administration of Th2 polarized cells did not alter the CD4-/- 
phenotype with respect to the capacity to mount collateral response to 
artery occlusion. These results suggest that T helper 1 may play as positive 
regulators of collateral responses. In contrast Th2 cells may have a neutral role 
in arteriogenesis although we cannot formally exclude that an hypothetical 
inhibitory effect of Th2 might have not be revealed because of the intrinsic 
impairment of the CD4-/- recipient mice in developing collateral circulation. 
The identification of specific circulating cellular subsets playing either as 
positive or negative regulators of collaterals growth may be exploited for the 
identification of novel easily detectable molecular markers for the assessment 
of the individual capacity to compensate vascular occlusion, which could 
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potentially represent reliable markers of individual cardiovascular risk. 
Hopefully, they could also become new molecular targets for the design of 
novel therapeutic approaches for peripheral and cardiac ischemic diseases. 
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